Blunting of ACTH response to human CRH in depressed patients is avoided by metyrapone pretreatment.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Biological Psychiatry

• Publication date

  1988-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0006-3223(88)90254-5PMID 2852510
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blunted aldosterone and ACTH release after human CRH administration in depressed patients.

  1987cited by this paper
• CRF: its regulation of ACTH and pro-opiomelanocortin peptide release and its extra hypothalamic occurrence.

  1986cited by this paper
• Human corticotropin-releasing hormone in depression--correlation with thyrotropin secretion following thyrotropin-releasing hormone.

  1986cited by this paper
• Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications.

  1986cited by this paper
• Corticotropin-releasing factor stimulation of adrenocorticotropin and beta-endorphin release: effects of acute and chronic stress.

  1985cited by this paper
• Regulation of corticotropin-releasing factor (CRF) receptors in the rat pituitary gland: effects of adrenalectomy on CRF receptors and corticotroph responses.

  1985cited by this paper
• Corticotropin-Releasing Factor Stimulation of Adrenocorticotropin and β-Endorphin Release: Effects of Acute and Chronic Stress

  1985cited by this paper
• Corticotropin-releasing factor regulates proopiomelanocortin messenger ribonucleic acid levels in vivo.

  1984cited by this paper
• Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells.

  1983cited by this paper
• Mechanisms of action of corticotropin-releasing factor and other regulators of corticotropin release in rat pituitary cells.

  1983cited by this paper
• Single-dose metyrapone test: review of a four-year experience.

  1975cited by this paper
• Single-dose metyrapone test.

  1970cited by this paper

• Ketamine Reverses Chronic Corticosterone-Induced Behavioral Deficits and Hippocampal Synaptic Dysfunction by Regulating eIF4E/BDNF Signaling.

  2024cites this paper
• Precision Psychiatry Approach to Treat Depression and Anxiety Targeting the Stress Hormone System – V1b-antagonists as a Case in Point

  2024cites this paper
• The pathophysiology and management of depression in cardiac surgery patients

  2023cites this paper
• Major depressive disorder and bistability in an HPA-CNS toggle switch

  2023cites this paper
• Vasopressin V1B Receptor Antagonists as Potential Antidepressants

  2021cites this paper
• A new model for the HPA axis explains dysregulation of stress hormones on the timescale of weeks

  2020cites this paper
• Hormonal dysregulation after prolonged HPA axis activation can be explained by 2 changes of adrenal and corticotroph masses

  2020cites this paper
• Psychoneuroendokrinologische Grundlagen psychischer Erkrankungen

  2017cites this paper
• The effect of NMDA receptor antagonists and antidepressants on resting state in major depressive disorder

  2015cites this paper
• Oestrogen: an overlooked mediator in the neuropsychopharmacology of treatment response?

  2011cites this paper
• The Hypothalamic-Pituitary-Adrenal Axis in Depression

  2010cites this paper
• The Interacting Neuroendocrine Network in Stress-Inducing Mood Disorders

  2010cites this paper
• Laboratorial Diagnosis of Cushing’s Syndrome: Differential Diagnosis with Pseudo Cushing’s Conditions as Obesity, Alcoholism and Depression

  2010cites this paper
• 92 – The Neuroendocrinology of Mood Disorders

  2009cites this paper
• Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.

  2009cites this paper
• Depression: Phenomenology, Epidemiology, and Pathophysiology

  2009cites this paper
• Neuroendokrinologische und psychoneuroimmunologische Grundlagen psychischer Erkrankungen

  2008cites this paper
• endocrine scars of of sustained childhood abuse in adult female patients with borderline personality disorder

  2007cites this paper
• Metyrapone: Basic and Clinical Studies*

  2007cites this paper
• The Biological Underpinnings of Depression.

  2006cites this paper
• Advances in Understanding Neuroendocrine Alterations in PTSD and Their Therapeutic Implications

  2006cites this paper
• Affektive Störungen — Neurobiologie

  2006cites this paper
• Magnetic resonance in patients with affective illness

  2005cites this paper
• Hypothesis: Cytokines may be activated to cause depressive illness and chronic fatigue syndrome

  2005cites this paper
• The combined T3/TRH test in depressed patients and healthy controls.

  2005cites this paper
• Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity

  2004cites this paper
• CRSN Symposium : Focus on Depression , Part I Symposium du CRSN : le point sur la dépression , première partie Implication of the hypothalamic – pituitary – adrenal axis in the physiopathology of depression

  2004cites this paper
• Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression.

  2004cites this paper
• Metyrapone tests in patients with panic disorder.

  2004cites this paper
• Invited review: the evolution of antidepressant mechanisms

  2004cites this paper
• Neuroendokrinologische un psychoneuroimmunologische Grundlagen psychiatrischer Erkrankungen

  2003cites this paper
• A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression

  2003cites this paper
• Cerebrospinal Fluid Corticotropin-Releasing Factor (CRF) and Vasopressin Concentrations Predict Pituitary Response in the CRF Stimulation Test: A Multiple Regression Analysis

  2003cites this paper
• Untersuchungen zu Änderungen der Hypothalamus-Hypophysen-Nebennierenrinden-Achse, des Schlafes und des Verhaltens bei Mäusen unter basalen und stressinduzierenden Bedingungen nach freiwilliger Benutzung eines Laufrades

  2003cites this paper
• Endocrine and Cardiovascular Responses to Corticotropin-Releasing Hormone in Patients with Posttraumatic Stress Disorder: A Role for Atrial Natriuretic Peptide?

  2003cites this paper
• Neuroendocrine aspects of hypercortisolism in major depression.

  2003influential citation
• Vasopressin as a target for antidepressant development: an assessment of the available evidence.

  2002cites this paper
• Neuroendocrine abnormalities in fibromyalgia

  2002cites this paper
• The Neuroendocrinology of Affective Disorders

  2002cites this paper
• Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse.

  2002cites this paper
• Corticotropin-releasing hormone in depression and post-traumatic stress disorder.

  2001cites this paper
• The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal.

  2001cites this paper
• The Hypothalamic-Pituitary-Adrenal Axis in Major Depressive Disorder: A Brief Primer for Primary Care Physicians.

  2001cites this paper
• Psychoneurendocrinology: a science of the past or a new pathway for the future?

  2000cites this paper
• Hormonal Evidence for Altered Responsiveness to Social Stress in Major Depression

  2000cites this paper
• The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety.

  1999cites this paper
• Separation induced changes in squirrel monkey hypothalamic-pituitary-adrenal physiology resemble aspects of hypercortisolism in humans.

  1999cites this paper
• Cytokines, Stress, and Depression

  1999cites this paper
• Regulation of corticosteroid receptor gene expression in depression and antidepressant action.

  1999cites this paper
• Delayed effects of stress and immune activation.

  1999cites this paper
• Cross-sensitization between immune and non-immune stressors. A role in the etiology of depression?

  1999cites this paper
• Psychoneuroendocrinology: A Scientific Domain of the Future or a Dream From the Past?

  1998cites this paper
• Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis.

  1998cites this paper
• The role of corticotropin releasing factor in depressive illness: a critical review.

  1998cites this paper
• Normal pituitary response to metyrapone in the morning in depressed patients: implications for circadian regulation of corticotropin-releasing hormone secretion.

  1997cites this paper
• Persistent changes in corticotropin-releasing factor systems due to early life stress: relationship to the pathophysiology of major depression and post-traumatic stress disorder.

  1997cites this paper
• The neuroendocrinology of depression and chronic stress.

  1996cites this paper
• Antidepressants and hypothalamic-pituitary-adrenocortical regulation.

  1996cites this paper
• Corticotropin-releasing hormone challenge in prepubertal major depression.

  1996cites this paper
• Evidence against changes in corticotroph CRF receptors in depressed patients.

  1995cites this paper
• Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?

  1995cites this paper
• Continuous administration of human corticotropin-releasing hormone in the absence of glucocorticoid feedback in man.

  1995cites this paper
• Social effects and circadian rhythms in squirrel monkey pituitary-adrenal activity.

  1995cites this paper
• Socioregulatory effects on squirrel monkey pituitary-adrenal activity: a longitudinal analysis of cortisol and ACTH.

  1994cites this paper
• Affective disorders and endocrine disease. New insights from psychosomatic studies.

  1994cites this paper
• Steroid Effects on Central Neurons and Implications for Psychiatric and Neurological Disorders

  1994cites this paper
• Dexamethasone nonsuppression in transgenic mice expressing antisense RNA to the glucocorticoid receptor.

  1994cites this paper
• Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome.

  1993cites this paper
• Thyroid and Adrenal Dysfunction in Abstinent Alcoholic Men: Locus of Disturbance

  1993cites this paper
• Pituitary and Adrenal Changes in Depression

  1993cites this paper
• The Role of Corticotropin-Releasing Factor in the Pathophysiology of Psychiatric Disorders

  1993cites this paper
• Stimulation of the pituitary-adrenal system with graded doses of CRH and low dose vasopressin infusion in depressed patients and healthy subjects: a pilot study.

  1993cites this paper
• HPA axis function in depression and dementia: A review

  1993cites this paper
• Adrenal steroid receptor activation in rat brain and pituitary following dexamethasone: implications for the dexamethasone suppression test.

  1992cites this paper
• In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients.

  1992cites this paper
• The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia.

  1992cites this paper
• Effect of metyrapone on the pituitary-adrenal axis in depression: relation to dexamethasone suppressor status.

  1992cites this paper
• Stimulation of the pituitary-adrenal axis with a low dose [Arg8]-vasopressin in depressed patients and healthy subjects.

  1992cites this paper
• Corticotropin-releasing hormone in humans.

  1992cites this paper
• Pituitary size in depression.

  1991cites this paper
• Disturbed glucocorticoid receptor autoregulation and corticotropin response to dexamethasone in depressives pretreated with metyrapone.

  1991cites this paper
• Effect of age on the cortisol response to human corticotropin-releasing hormone in depressed patients pretreated with dexamethasone.

  1991cites this paper
• NEUROENDOCRINE CHALLENGE TESTS IN AFFECTIVE DISORDERS: IMPLICATIONS FOR FUTURE PATHOPHYSIOLOGICAL INVESTIGATIONS

  1991cites this paper
• Melancholia and MRI.

  1991cites this paper
• Effects of metyrapone and dexamethasone upon pro-gamma-MSH plasma levels in depressed patients and healthy controls.

  1990cites this paper
• Cortisol Response to Corticotropin Releasing Hormone in Dexamethasone-Pretreated Patients with Depression

  1990cites this paper
• Adrenocortical function, social rank, and personality among wild baboons

  1990cites this paper
• Augmented pituitary corticotropin response to a threshold dosage of human corticotropin-releasing hormone in depressives pretreated with metyrapone.

  1989cites this paper
• Human corticotropin releasing hormone: clinical studies in patients with affective disorders, alcoholism, panic disorder and in normal controls.

  1988cites this paper
• Implications of altered limbic‐hypothalamicpituitary‐adrenocortical (LHPA)‐function for neurobiology of depression

  1988cites this paper
• Response of ACTH and cortisol to human corticotropin-releasing hormone after short-term abstention from alcohol abuse.

  1988cites this paper